Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1657 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Ranaz Names New Chief Financial Officer

Mr Guay is a chartered accountant since 1974 and has a number of years of experience in business management. During his career, he has worked for such companies

Amgen Q1 Total Revenues Up 9%

Amgen has posted a net income of $1.16bn for the first quarter 2010, or $1.18 per diluted share, compared to $1.01bn, or $0.98 per diluted share, for the

Genzyme Q1 Total Revenues Down

Genzyme posted a net loss of $114.95m for the first quarter 2010, or $0.43 per diluted share, compared to net income of $195.48m, or $0.70 per diluted share,